Loading clinical trials...
Loading clinical trials...
A Phase III Study Evaluating the Efficacy and Safety of CLS2901C in Patients With Osteoarthritis of the Knee
Conditions
Interventions
CLS2901C (human [allogeneic] chondrocyte sheets)
Locations
6
Japan
Ebina General Hospital/Ebina Medical Plaza
Ebina, Kanagawa, Japan
Tokai University Hospital
Isehara, Kanagawa, Japan
Yokohama Sekishinkai Hospital
Yokohama, Kanagawa, Japan
Yokohama City University Medical Center
Yokohama, Kanagawa, Japan
Yokohama Minami Kyousai Hospital
Yokohama, Kanagawa, Japan
Juntendo University Hospital
Bunkyō-Ku, Tokyo, Japan
Start Date
October 20, 2023
Primary Completion Date
July 31, 2027
Completion Date
July 31, 2031
Last Updated
November 24, 2025
NCT04992624
NCT07193368
NCT06927934
NCT06717529
NCT03005873
NCT02116972
Lead Sponsor
CellSeed Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions